InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Behrenbruch Christian, Chief Executive Officer. Director active across 1 company, notably Telix Pharmaceuticals Ltd. Cumulatively, 2 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €853k. History available since 28 April 2026. The latest transaction was filed on 28 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
34,500 shares@ US$14.480.017% mcap50.0% of flowOrdinary SharesSEC:0001628280-26-031608:0
Ideal exit: 23 Jan 2027 (T+270)
34,500 shares@ US$14.480.017% mcap50.0% of flowOrdinary SharesSEC:0001628280-26-031608
Ideal exit: 23 Jan 2027 (T+270)
2 of 2 declarations
About Behrenbruch Christian
Christian Behrenbruch is the MD & Group CEO at Telix Pharmaceuticals Ltd. He leads the company's operations and development strategies, ensuring its growth and profitability. His experience in the pharmaceutical sector enables him to navigate effectively in a complex environment.
